Carcinogenesis and epidemiology of cervical cancer: The hallmark of human papillomavirus-associated cancer

被引:0
|
作者
Kobayashi, Osamu [1 ]
Kamata, Saki [1 ]
Okuma, Yuki [1 ]
Nakajima, Takahiro [1 ]
Ikeda, Yuji [1 ]
Saito, Keisuke [1 ]
Kawana, Kei [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Obstet & Gynecol, 30-1 Oyaguchi kamimachi,Itabashi Ku, Tokyo 1738610, Japan
关键词
carcinogenesis; cervical cancer; epidemiology; human papillomavirus (HPV); NATURAL-HISTORY; INFECTION; CONSERVATION; INCOME;
D O I
10.1111/jog.15997
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Cervical cancer affects women worldwide and is the most common human papillomavirus (HPV)-associated cancer. Carcinogenesis caused by HPV results in specific cancer behavior because of the underlying viral infection. The mechanism and timing of the transformation from viral infection to cancer cells have been elucidated in detail. Treatments for this cancer are based on its characteristics and are being implemented. Moreover, HPV infection is widespread worldwide and is transmitted through sexual activity. Although the HPV vaccination is the most effective strategy of preventing cervical cancer, it is not feasible to vaccinate the entire human population especially in low- and middle-income countries. In order to consider the next step for HPV vaccination, we need to understand the characteristics of HPV carcinogenesis and cervical cancer. Additionally, treatment aimed at preservation of reproductive function in patients with cervical cancer is often required, as the cervix is a reproductive organ and because the disease is more prevalent in the adolescent and young adult generation. Thus, there are still many challenges in the diagnosis, treatment, and prevention of cervical cancer.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [1] Carcinogenesis and management of human papillomavirus-associated cervical cancer
    Misako Kusakabe
    Ayumi Taguchi
    Kenbun Sone
    Mayuyo Mori
    Yutaka Osuga
    International Journal of Clinical Oncology, 2023, 28 : 965 - 974
  • [2] Carcinogenesis and management of human papillomavirus-associated cervical cancer
    Kusakabe, Misako
    Taguchi, Ayumi
    Sone, Kenbun
    Mori, Mayuyo
    Osuga, Yutaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (08) : 965 - 974
  • [3] Immune evasion in human papillomavirus-associated cervical cancer
    Tindle, RW
    NATURE REVIEWS CANCER, 2002, 2 (01) : 59 - 65
  • [4] Immune evasion in human papillomavirus-associated cervical cancer
    Robert W. Tindle
    Nature Reviews Cancer, 2002, 2 : 59 - 64
  • [5] Role of extracellular vesicle in human papillomavirus-associated cervical cancer
    Dong, Shixiang
    Zhang, Yan
    Wang, Yankui
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (17) : 16203 - 16212
  • [6] TREATMENT AND COFACTOR STUDIES FOR HUMAN PAPILLOMAVIRUS-ASSOCIATED CERVICAL CANCER
    Alam, Samina
    Bowser, Brian
    Meyers, Craig
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3405 - 3406
  • [7] Role of extracellular vesicle in human papillomavirus-associated cervical cancer
    Shixiang Dong
    Yan Zhang
    Yankui Wang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16203 - 16212
  • [8] Human Papillomavirus-Associated Oropharyngeal Cancer
    Dahlstrom, Kristina R.
    Anderson, Karen. S.
    Sturgis, Erich M.
    JAMA ONCOLOGY, 2017, 3 (02) : 161 - 162
  • [9] SEROLOGIC RESPONSE IN HUMAN PAPILLOMAVIRUS-ASSOCIATED INVASIVE CERVICAL-CANCER
    VISCIDI, RP
    SUN, Y
    TSUZAKI, B
    BOSCH, FX
    MUNOZ, N
    SHAH, KV
    INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) : 780 - 784
  • [10] Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications
    Ndon, Sifon
    Singh, Amritpal
    Ha, Patrick K.
    Aswani, Joyce
    Chan, Jason Ying-Kuen
    Xu, Mary Jue
    CANCERS, 2023, 15 (16)